Identifying patients at high risk of breast cancer recurrence: strategies to improve patient outcomes
- PMID: 26504408
- PMCID: PMC4603628
- DOI: 10.2147/BCTT.S91981
Identifying patients at high risk of breast cancer recurrence: strategies to improve patient outcomes
Abstract
Identifying patients at high risk of breast cancer recurrence has important implications not only for enabling the ability to provide accurate information to patients but also the potential to improve patient outcomes. Patients at high recurrence risk can be offered appropriate treatment to improve the overall survival. However, the major challenge is identifying patients with early-stage breast cancer at lower risk who may be spared potentially toxic therapy. The successful integration of molecular assays into clinical practice may address the problem of overtreatment and improve overall patient outcomes.
Keywords: breast cancer; early stage; genomic assays; recurrence risk; recurrence score.
References
-
- Bishop HM, Blamey RW. A suggested classification of breast pain. Postgrad Med J. 1979;55(Suppl 5):59–60. - PubMed
-
- Williams C, Brunskill S, Altman D, et al. Cost-effectiveness of using prognostic information to select women with breast cancer for adjuvant systemic therapy. Health Technol Assess. 2006;10(34):iii–iv. ix–xi, 1–204. - PubMed
-
- Goldhirsch A, Glick JH, Gelber RD, Senn HJ. Meeting highlights: International Consensus Panel on the Treatment of Primary Breast Cancer. J Natl Cancer Inst. 1998;90(21):1601–1608. - PubMed
Publication types
LinkOut - more resources
Full Text Sources
Other Literature Sources
